Impact Healthcare - Notice of AGM
31/03/2023 17:10
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230331:nRSe0003Va&default-theme=true
RNS Number : 0003V Impact Healthcare REIT PLC 31 March 2023
31 March 2023
IMPACT HEALTHCARE REIT PLC
("Impact" or the "Company" or, together with its subsidiaries, the "Group")
2023 Notice of Annual General Meeting
The Board of Directors of Impact Healthcare REIT plc (ticker: IHR), the real
estate investment trust which gives investors exposure to a diversified
portfolio of UK healthcare real estate assets, in particular care homes, is
pleased to announce that the 2023 Notice of Annual General Meeting is now
available to view on the Company's website at
https://www.impactreit.uk/investors/reporting-centre/
(https://www.impactreit.uk/investors/reporting-centre/) .
The Company's Annual General Meeting will be held at 11.00 a.m. on Wednesday,
17 May 2023, at the offices of Travers Smith LLP, 10 Snow Hill, London EC1A
2AL.
The formal Notice of the Annual General Meeting will be posted to those
shareholders who have requested that the Company should continue with postal
correspondence and in accordance with Listing Rule 9.6.1 has been submitted to
the Financial Conduct Authority and will shortly be available for inspection
from the National Storage Mechanism at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .
This year's Annual General Meeting will follow its usual format as the Board
considers it important that Shareholders continue to have opportunities to
engage with it.
The Board also encourages Shareholders to vote on any of the matters of
business at the AGM in advance by proxy.
If circumstances change before the AGM, the Company will consider making
appropriate changes and if it is appropriate notify shareholders of any
changes to the proposed format for the AGM as soon as possible via RIS and its
website (https://www.impactreit.uk/investors/reporting-centre/
(https://www.impactreit.uk/investors/reporting-centre/) ).
FOR FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP Via Maitland/AMO
Mahesh Patel
Andrew Cowley
Maitland/AMO (Communications adviser) +44 7747 113 930
James Benjamin impacthealth-maitland@maitland.co.uk
(mailto:impacthealth-maitland@maitland.co.uk)
The Company's LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at
www.impactreit.uk (http://www.impactreit.uk) .
This information is provided by RNS, the news service of the London Stock
Exchange. RNS is approved by the Financial Conduct Authority to act as a
Primary Information Provider in the United Kingdom. Terms and conditions
relating to the use and distribution of this information may apply. For
further information, please contact rns@lseg.com (mailto:rns@lseg.com) or
visit www.rns.com (http://www.rns.com/) .
RNS may use your IP address to confirm compliance with the terms and
conditions, to analyse how you engage with the information contained in this
communication, and to share such analysis on an anonymised basis with others
as part of our commercial services. For further information about how RNS and
the London Stock Exchange use the personal data you provide us, please see
our Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy) .
END
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NOAJBMFTMTMJBPJ